Publications
Haglof K., Popa E., Hochster H. “Recent developments in the clinical activity of topoisomerase-1 inhibitors” UPDATE ON CANCER THERAPEUTICS I pp.117-145; Elsevier Ltd.,UK 2006
Hochster HS, Luo W, Popa EC, Lyman BT, Mulcahy M, Beatty PA, Benson AB.
Abstract
Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299. J Clin Oncol. 2007 Dec 1;25(34):5397-402.
Siegel AB, Cohen EI, Ocean A, Lehrer D, Goldenberg A, Knox JJ, Chen H, Clark-Garvey S, Weinberg A, Mandeli J, Christos P, Mazumdar M, Popa E, Brown RS Jr, Rafii S, Schwartz JD.
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.
J Clin Oncol. 2008 Jun 20;26(18):2992-8.
